Qube Research & Technologies (QRT)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Sell
2,000
-23,400
-92% -$2.05M ﹤0.01% 2925
2026
Q1
$2.16M Sell
25,400
-45,500
-64% -$4.06M ﹤0.01% 2122
2025
Q4
$5.6M Buy
70,900
+53,500
+307% +$4.19M 0.01% 1703
2025
Q3
$1.39M Sell
17,400
-37,600
-68% -$3.21M ﹤0.01% 2389
2025
Q2
$5M Buy
55,000
+53,600
+3,829% +$4.89M 0.01% 1695
2025
Q1
$131K Buy
1,400
+500
+56% +$44.8K ﹤0.01% 2956
2024
Q4
$81.8K Buy
900
+600
+200% +$57.3K ﹤0.01% 3026
2024
Q3
$31.1K Buy
+300
New +$30.6K ﹤0.01% 2923

Other funds holding CL

Qube Research & Technologies (QRT)'s CL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Colgate-Palmolive (CL) stake by 72% in Q2 2026, selling an estimated $153M and leaving 669,266 shares worth $61.4M. The position accounts for 0.06% of the portfolio, ranked #430.

Qube Research & Technologies (QRT) first reported a position in CL in Q1 2018 and has held it in 28 quarters since. The position peaked at $406M in Q1 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 669,266 shares of Colgate-Palmolive worth $61.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,752,027 Colgate-Palmolive shares in Q2 2026, an estimated $153M.
  • Colgate-Palmolive made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #430 holding.
  • Qube Research & Technologies (QRT) first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 28 quarters since.
  • Qube Research & Technologies (QRT)'s Colgate-Palmolive position peaked at $406M in Q1 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.